Ryo Ogawara

Ryo Ogawara

Auto-generated profile, based on publicly available information

Ryo Ogawara

Department of Cardiovascular Medicine, Fukushima Medical University , 1 Hikarigaoka, Fukushima 960-1295

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
SIShohei Ichimura
Shohei Ichimura
TMTomofumi Misaka
Tomofumi Misaka
RORyo Ogawara
Ryo Ogawara
YTYusuke Tomita
Yusuke Tomita
FAFumiya Anzai
Fumiya Anzai
YTYasuchika Takeishi
Yasuchika Takeishi
BACKGROUND: The immune systems and chronic inflammation are implicated in the pathogenesis of dilated cardiomyopathy (DCM) and heart failure. However, the significance of neutrophil extracellular traps (NETs) in heart failure remains to be elucidated. METHODS: We enrolled consecutive 62 patients with heart failure with idiopathic DCM who underwent endomyocardial biopsy. Biopsy specimens were subjected to fluorescent immunostaining to detect NETs, and clinical and outcome data were collected. Ex vivo and in vivo experiments were conducted. RESULTS: The numbers of NETs per myocardial tissue area and the proportion of NETs per neutrophil were significantly higher in patients with DCM compared with non-DCM control subjects without heart failure, and the numbers of NETs were negatively correlated with left ventricular ejection fraction. Patients with DCM with NETs (n=32) showed lower left ventricular ejection fraction and higher BNP (B-type natriuretic peptide) than those without NETs (n=30). In a multivariable Cox proportional hazard model, the presence of NETs was independently associated with an increased risk of adverse cardiac events in patients with DCM. To understand specific underlying mechanisms, extracellular flux analysis in ex vivo revealed that NETs-containing conditioned medium from wild-type neutrophils or purified NET components led to impaired mitochondrial oxygen consumption of cardiomyocytes, while these effects were abolished when PAD4 (peptidyl arginine deiminase 4) in neutrophils was genetically ablated. In a murine model of pressure overload, NETs in myocardial tissue were predominantly detected in the acute phase and persisted throughout the ongoing stress. Four weeks after transverse aortic constriction, left ventricular ejection fraction was reduced in wild-type mice, whereas PAD4-deficient mice displayed preserved left ventricular ejection fraction without inducing NET formation. CONCLUSIONS: NETs in myocardial tissue contribute to cardiac dysfunction and adverse outcomes in patients with heart failure with DCM, potentially through mitochondrial dysfunction of cardiomyocytes.

16 April 2026 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
AOAkito Okabe
Akito Okabe
AYAKIOMI YOSHIHISA
AKIOMI YOSHIHISA
YSYu Sato
Yu Sato
NONaoto Ohashi
Naoto Ohashi
SOSatoshi Okochi
Satoshi Okochi
YTYasuchika Takeishi
Yasuchika Takeishi
Aims: Seasonal factors, particularly during winter, have been associated with worsened heart failure (HF). However, seasonal differences in clinical characteristics, clinical outcomes, and environmental mechanisms remain unclear. Methods and results: We analysed 2857 patients hospitalized for HF. Patients were classified into four groups by season of admission: spring (March to May, n = 788, 27.6%), summer (June to August, n = 699, 24.5%), fall (September to November, n = 645, 22.6%), and winter (December to February, n = 725, 25.4%). Baseline characteristics, clinical outcomes, and environmental factors corresponding to the admission month—such as temperature, atmospheric pressure, relative humidity, sunshine duration, influenza activity, and PM2.5 concentration—were compared among the groups. The winter group was older and more frequently had hypertension, diabetes, chronic kidney disease, and thyroid disease. No seasonal differences were observed in sex, body mass index, HF aetiology, other comorbidities, B-type natriuretic peptide levels, or left ventricular ejection fraction. Compared with the fall group, the winter group was associated with higher risk of in-hospital cardiac and all-cause, 90-day cardiac, and all-cause mortality (odds ratio 2.13, 1.85, 1.69, 2.01, 1.80, respectively, P < 0.05). With respect to environmental factors, (i) lower temperature was associated with 90-day cardiac and all-cause mortality; (ii) shorter sunshine duration was associated with 90-day all-cause mortality; and (iii) higher PM2.5 concentrations were associated with in-hospital cardiac mortality. In contrast, atmospheric pressure, relative humidity, and influenza activity were not associated with clinical outcomes. Conclusion: Winter admission for HF was associated with older age, more comorbidities, and higher in-hospital and short-term mortality, which may be partly explained by lower temperatures and shorter sunlight.